Medical Cannabis

Articles

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

Civil Lawsuit Accuses Arkansas' Largest Cannabis Testing Laboratory of Conspiring with Cultivators to Inflate THC Levels

The House and Senate introduced a revised bill to mandate Veterans Affairs (VA) to conduct research on the effects of medical cannabis on veterans with post-traumatic stress disorder (PTSD) and chronic pain. 

House and Senate Introduce Bill to Direct Veterans Affairs to Study Medical Cannabis to Treat Certain Conditions

In results from a recent study, respondents reported that cannabis use led them to decrease their use of pharmacological treatments, including opioids.

New Study Published on Use of Cannabis and Other Pain Treatments Among Adults with Chronic Pain

This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.

From Contaminated Cannabis Material to Microbe-Free Extracts: A Real-World Test

The 2022 Canna Pharma Conference was held October 12-13 in San Diego, California.

Highlights from Canna Pharma 2022: Driving Cannabis Science and Therapeutics Forward

In the work presented here, the author shares research from collecting reports from the New Jersey State laboratory (the Department of Health’s Environmental and Chemical Laboratory Services), which has conducted testing for the state’s medicinal program. He documented an average variance of 20% in potency levels from different samples of the same test lot.

Degree of Variance in THC Levels in Samples Taken from Single Lots  of Medical Cannabis

Dr. Stephen Barnhill, founder, chairman, and CEO of Apollon Formularies, plc., explained to Cannabis Science Conference East 2022 attendees, his findings on how cannabis and mushrooms can be the ultimate weapon in the war against cancer.

Cannabis and Mushrooms and Their Tale to Treating Cancer

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


In this interview, Dr. David “Dedi” Meiri discusses his important work at Technion, challenges and opportunities in cannabis research, and a preview of his upcoming presentation for CSC East.

2022 CSC East Plenary Speaker Highlight: Dr. Dedi Meiri

Otha Smith III shares his personal journey with medical cannabis and how it led to founding the Tetragram app.

Tetragram Provides Cannabis Users a Safe Environment to Explore the Medicinal Benefits of the Plant

In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.

Medical Cannabis Is Here and It’s Here to Stay: How Americans for Safe Access, the Nation’s Largest Member-Based Cannabis Advocacy Organization, Protects Patient Rights